��躰�肽𨯙嚙踝蕭�椬��㮖����𠺪蕭��辷蕭
��躰�頣蕭皛抵�䈑蕭嚙踝蕭膌见�躰�肽𨯙
��躰�肽𨯙嚙踝蕭颲瑁𨯙�𢥫嚙質�嚙踢�𧶏蕭薳��𨯙
��躰釭嚙賢��𨯙嚙賡ㄤ��躰釭嚙賭�對蕭嚙�
��躰釭嚙賢��𨯙嚙踝蕭蒺矋蕭嚙賣���辷蕭
��躰�頣蕭嚙質𨯙��鞱�矋蕭��躰�肽𨯙嚙踢岡芾働嚙�
��躰�頣蕭皛抵�䈑蕭嚙踝蕭嚙賢�磰𨯙嚙踢﹜���躰�肽𨯙��躰�肽𨯙
嚙賭麩��躰�肽𨯙嚙賭�𡑒𨯙��躰�肽𨯙��躰�肽𨯙
��躰腺鈭�䁥滩𨯙嚙賡�嚙踝蕭��躰�頣蕭�迚�𨯙
��躰�肽𨯙嚙踝蕭嚙踢�佅嚙賢�躰�肽𨯙嚙踝蕭�迚�𨯙
��躰�肽𨯙嚙賜�嚙踝蕭臐�鳴蕭�莎蕭撠𩤃蕭臐�航𨯙��躰郭嚙踢岸��𨯙��辷蕭
��躰�肽𨯙��躰�肽𨯙嚙賡做嚙踢╱ｇ蕭暻芸�躰腺�𧊋臐�航𨯙��躰�肽𨯙
嚙踝蕭��嚙質�磰𨯙��躰�肽𨯙嚙賢䐓��躰釭臐�嚙踝蕭嚙踝蕭��辷蕭
��躰釭嚙賢��𨯙嚙踢�鍦�躰�栶�笔�辷蕭
��躰都嚙賢�躰腺嚙賬���躰腺嚙賢��
��躰酗��𥕦�躰郭��嚙賢��𨯙��鮋ㄙ
��躰都嚙賢�躰腺嚙賬���躰�肽𨯙��躰�肽𨯙��辷蕭
��躰都嚙賢�躰腺嚙賬�嚙踝蕭嚙質𨯙��躰�肽𨯙
��躰酗藆�坿���嚙質�𨅯�𡑒��𨯙��辷蕭
��躰酗��𨥈蕭嚙踢�航𨯙嚙踝蕭嚙踝蕭臐��𨯙
嚙踢坎萘���朞𨯙�坾蝞�嚙賢�躰�肽𨯙��辷蕭
��躰閉瘣賢�躰酗嚙踢�航𨯙�����𨯙��辷蕭
嚙踢△�嚙踝蕭嚙質𨯙嚙踝蕭璇寡𨯙��辷蕭
��躰�肽𨯙��躰腺銝滚��𨯙��躰�肽𨯙��躰�肽𨯙
��躰�肽𨯙��𥕦�页蕭���𧒆䕘蕭薴ㄟ��躰腺��舘�舘𨯙
��躰腺鈭�䁥滩𨯙嚙賡�嚙踢�𦴣��躰�肽𨯙��躰�肽𨯙
��躰閉�蕟��躰�肽𨯙��嚙踝蕭�𨯙��琜蕭藃�讛𨯙��辷蕭
嚙踝蕭薳閦�𥕦�𩤃蕭嚙質𨯙��躰�肽𨯙��躰�肽𨯙
嚙踝蕭薳閦�𥕦�𩤃蕭嚙質𨯙��躰部薴钟��辷蕭
��躰腺嚙賣�坿𨯙��嚙賣Ⅰ�𨯙��躰�肽𨯙��辷蕭
��躰腺嚙賣�坿𨯙��嚙賜�橘蕭嚙質�芷礆嚙�
嚙踝蕭臐号艟洽嚙踝蕭��磰𨯙��躰�肽𨯙��辷蕭
��躰�肽𨯙嚙賢𠘕嚙賢𠹭��㚁蕭銧游�辷蕭
��躰�肽𨯙��𥟇䠋�𨯙��躰�肽𨯙��𥪮�航𨯙
嚙踝蕭�緾嚙賢�躰郭嚙賭�𡑒𨯙嚙踝蕭嚙�
��躰�肽𨯙嚙踢╱Ｚ躀臐��𨯙��躰�肽𨯙��辷蕭
嚙踝蕭艟妟��𥕦�躰郭嚙賭�𤏸𨯙��躰�肽𨯙��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭嚙踝蕭�佞𧒆��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭擗�𠯫�𧒆��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭憍辷蕭�莎蕭嚙質鷄嚙踝蕭
��躰�肽𨯙��𥕦��𨯙嚙賜�皜脩腦嚙踢𧒆��辷蕭
��躰�肽𨯙��𥕦��𨯙嚙賜�皜賂蕭�樹𧒆��辷蕭
嚙踝蕭艟妟��𥕦�躰釭�𡁜�躰腺嚙踝蕭藂��𨯙��躰釭蝮�蕭�𧒆��辷蕭
嚙踝蕭艟妟��𥕦�躰釭�𡁜�躰腺嚙踝蕭藂��𨯙��躰郭嚙賜�樹𧒆��辷蕭
��躰腺�亙�滩𨯙��躰�頣蕭��𡏭𨯙��躰�肽𨯙�����痹蕭嚙�
��躰�肽𨯙嚙踢𧒆䕘蕭嚙踢孜讛𨯙��躰�肽𨯙��辷蕭
嚙踝蕭���蕭�䁥滩𨯙��琜蕭�迚�𨯙��辷蕭
��躰�肽𨯙��躰郭�𨺗��躰�肽𨯙
��躰�肽𨯙��躰�肽𨯙嚙踝蕭隤抵���嚙賬答�𨯙��躰�肽𨯙
大成鋼(2027)
月營收
季盈餘
2025/08/01
38.90元 (大成鋼股價)
2025/08/01
13.04% (年增率)
8,478百萬元 (營收)
大成鋼(2027) 年度營收走勢圖
12
7,283百萬/月 (110年)
7,239百萬/月 (111年)
6,177百萬/月 (112年)
6,422百萬/月 (113年)
N/A百萬/月 (114年)
大成鋼(2027)月營收明細
單位：仟元
年/月
營收
月增率
去年同期
年增率
累計營收
年增率
114/08
8,477,981
-1.83%
7,499,728
13.04%
68,689,958
10.57%
114/07
8,635,750
4.24%
7,290,028
18.46%
60,211,977
10.23%
114/06
8,284,678
1.22%
7,672,790
7.97%
51,576,227
8.97%
114/05
8,185,089
-9.16%
8,067,586
1.46%
43,291,549
9.16%
114/04
9,010,554
-0.90%
8,405,777
7.19%
35,106,460
11.13%
114/03
9,092,719
3.58%
7,598,327
19.67%
26,095,906
12.55%
114/02
8,778,777
6.74%
7,815,868
12.32%
17,003,187
9.08%
114/01
8,224,410
28.05%
7,771,619
5.83%
8,224,410
5.83%
113/12
6,422,712
-5.40%
6,177,627
3.97%
90,305,234
-10.91%
113/11
6,789,290
-15.65%
7,036,468
-3.51%
83,882,522
-11.88%
113/10
8,049,301
16.28%
8,473,628
-5.01%
77,093,232
-12.55%
113/09
6,922,208
-7.70%
8,054,404
-14.06%
69,043,931
-13.35%
113/08
7,499,728
2.88%
8,859,977
-15.35%
62,121,723
-13.27%
113/07
7,290,028
-4.99%
7,317,811
-0.38%
54,621,995
-12.97%
113/06
7,672,790
-4.89%
8,883,634
-13.63%
47,331,967
-14.64%
113/05
8,067,586
-4.02%
9,066,682
-11.02%
39,659,177
-14.83%
113/04
8,405,777
10.63%
8,447,799
-0.50%
31,591,591
-15.75%
113/03
7,598,327
-2.78%
10,222,131
-25.67%
23,185,814
-20.18%
113/02
7,815,868
0.57%
8,925,017
-12.43%
15,587,487
-17.20%
113/01
7,771,619
25.80%
9,901,517
-21.51%
7,771,619
-21.51%
112/12
6,177,627
-12.21%
7,239,664
-14.67%
101,366,695
-11.26%
112/11
7,036,468
-16.96%
7,520,371
-6.43%
95,189,068
-11.02%
112/10
8,473,628
5.20%
9,226,430
-8.16%
88,152,600
-11.37%
112/09
8,054,404
-9.09%
9,318,136
-13.56%
79,678,972
-11.70%
112/08
8,859,977
21.07%
9,582,826
-7.54%
71,624,568
-11.49%
112/07
7,317,811
-17.63%
8,854,430
-17.35%
62,764,591
-12.02%
112/06
8,883,634
-2.02%
10,189,220
-12.81%
55,446,780
-11.26%
112/05
9,066,682
7.33%
10,756,686
-15.71%
46,563,146
-10.96%
112/04
8,447,799
-17.36%
11,340,809
-25.51%
37,496,464
-9.72%
112/03
10,222,131
14.53%
12,152,616
-15.89%
29,048,665
-3.79%
112/02
8,925,017
-9.86%
8,994,745
-0.78%
18,826,534
4.35%
112/01
9,901,517
36.77%
9,047,135
9.44%
9,901,517
9.44%
111/12
7,239,664
-3.73%
7,283,767
-0.61%
114,223,068
17.68%
111/11
7,520,371
-18.49%
8,375,852
-10.21%
106,983,404
19.17%
111/10
9,226,430
-0.98%
8,887,169
3.82%
99,463,033
22.19%
111/09
9,318,136
-2.76%
8,717,185
6.89%
90,236,603
24.44%
111/08
9,582,826
8.23%
8,865,937
8.09%
80,918,467
26.84%
111/07
8,854,430
-13.10%
71,335,641
111/06
10,189,220
-5.28%
62,481,211
111/05
10,756,686
-5.15%
52,291,991
111/04
11,340,809
-6.68%
41,535,305
111/03
12,152,616
35.11%
30,194,496
111/02
8,994,745
-0.58%
18,041,880
111/01
9,047,135
24.21%
9,047,135
110/12
7,283,767
-13.04%
97,058,324
110/11
8,375,852
-5.75%
89,774,557
110/10
8,887,169
1.95%
81,398,705
110/09
8,717,185
-1.68%
72,511,536
說明：自2013年起上市櫃公司因IFRSs會計準則規範，每月公告的營收必須是合併營收，不再公告非合併營收。2012年(含)前，合併營收是採自願公告。
